128 related articles for article (PubMed ID: 7485348)
1. The impact of initiating a human immunodeficiency virus screening program in an urban obstetric population.
Lewis R; O'Brien JM; Ray DT; Sibai BM
Am J Obstet Gynecol; 1995 Oct; 173(4):1329-33. PubMed ID: 7485348
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
4. Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong.
Lee PM; Wong KH
Hong Kong Med J; 2007 Jun; 13(3):199-207. PubMed ID: 17548908
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of human immunodeficiency virus screening in pregnancy.
Ecker JL
Am J Obstet Gynecol; 1996 Feb; 174(2):716-21. PubMed ID: 8623812
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care.
Grobman WA; Garcia PM
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1062-71. PubMed ID: 10561619
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission.
Sansom SL; Jamieson DJ; Farnham PG; Bulterys M; Fowler MG
Obstet Gynecol; 2003 Oct; 102(4):782-90. PubMed ID: 14551009
[TBL] [Abstract][Full Text] [Related]
8. Universal HIV screening of pregnant women in England: cost effectiveness analysis.
Postma MJ; Beck EJ; Mandalia S; Sherr L; Walters MD; Houweling H; Jager JC
BMJ; 1999 Jun; 318(7199):1656-60. PubMed ID: 10373167
[TBL] [Abstract][Full Text] [Related]
9. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy.
Myers ER; Thompson JW; Simpson K
Obstet Gynecol; 1998 Feb; 91(2):174-81. PubMed ID: 9469271
[TBL] [Abstract][Full Text] [Related]
12. Screening for human immunodeficiency virus infection during pregnancy.
Ross EL; Morrison JC
Pediatr AIDS HIV Infect; 1997 Feb; 8(1):12-4. PubMed ID: 11361506
[TBL] [Abstract][Full Text] [Related]
13. [Pharmaco-economic evaluation of mandatory HIV-screening in pregnancy; a cost-efficacy analysis in Amsterdam].
Postma MJ; van den Hoek JA; Beck EJ; Heeg B; Jager JC; Coutinho RA
Ned Tijdschr Geneeskd; 2000 Apr; 144(16):749-54. PubMed ID: 10812443
[TBL] [Abstract][Full Text] [Related]
14. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
Rivera-Alsina ME; Rivera CC; Rollene N; Kirby RS; Ayres A; McNamara M
J Reprod Med; 2001 Mar; 46(3):243-8. PubMed ID: 11304866
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model].
Gómez M
Rev Panam Salud Publica; 2008 Oct; 24(4):256-64. PubMed ID: 19133174
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study.
Bristow CC; Larson E; Anderson LJ; Klausner JD
Sex Transm Infect; 2016 Aug; 92(5):340-6. PubMed ID: 26920867
[TBL] [Abstract][Full Text] [Related]
17. Mandatory screening of pregnant women for the human immunodeficiency virus.
Wilfert CM
Clin Infect Dis; 1994 Oct; 19(4):664-6. PubMed ID: 7605429
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
Rely K; Bertozzi SM; Avila-Figueroa C; Guijarro MT
Health Policy Plan; 2003 Sep; 18(3):290-8. PubMed ID: 12917270
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China.
Owusu-Edusei K; Tao G; Gift TL; Wang A; Wang L; Tun Y; Wei X; Wang L; Fuller S; Kamb ML; Bulterys M
Sex Transm Dis; 2014 Feb; 41(2):103-10. PubMed ID: 24413489
[TBL] [Abstract][Full Text] [Related]
20. Reducing perinatal HIV transmission in developing countries through antenatal and delivery care, and breastfeeding: supporting infant survival by supporting women's survival.
Berer M
Bull World Health Organ; 1999; 77(11):871-7. PubMed ID: 10612882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]